108 related articles for article (PubMed ID: 10222355)
1. Serum galactosyl hydroxylysine as a biochemical marker of bone resorption.
Al-Dehaimi AW; Blumsohn A; Eastell R
Clin Chem; 1999 May; 45(5):676-81. PubMed ID: 10222355
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children.
Rauch F; Schnabel D; Seibel MJ; Remer T; Stabrey A; Michalk D; Schönau E
J Clin Endocrinol Metab; 1995 Apr; 80(4):1295-300. PubMed ID: 7714103
[TBL] [Abstract][Full Text] [Related]
3. Collagen markers deoxypyridinoline and hydroxylysine glycosides: pediatric reference data and use for growth prediction in growth hormone-deficient children.
Rauch F; Georg M; Stabrey A; Neu C; Blum WF; Remer T; Manz F; Schoenau E
Clin Chem; 2002 Feb; 48(2):315-22. PubMed ID: 11805013
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
[TBL] [Abstract][Full Text] [Related]
5. The relationship between body composition and the urinary excretion of deoxypyridinoline and galactosyl-hydroxylysine in children and adolescents.
Fricke O; Land C; Beccard R; Semler O; Stabrey A; Schoenau E
J Bone Miner Metab; 2009; 27(6):689-97. PubMed ID: 19526303
[TBL] [Abstract][Full Text] [Related]
6. Urinary collagen metabolite excretion in amyotrophic lateral sclerosis.
Ono S; Shimizu N; Imai T; Rodriguez GP
Muscle Nerve; 2001 Jun; 24(6):821-5. PubMed ID: 11360267
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease.
Uebelhart D; Gineyts E; Chapuy MC; Delmas PD
Bone Miner; 1990 Jan; 8(1):87-96. PubMed ID: 2106358
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of collagen metabolites in protein malnutrition.
Sambasiva Rao J; Rao VH
J Clin Chem Clin Biochem; 1980 May; 18(5):287-91. PubMed ID: 7430958
[TBL] [Abstract][Full Text] [Related]
9. Bone biochemical markers for assessment of bone responses to differentiated phosphorus supply in growing-finishing pigs.
Sørensen KU; Kruger MC; Hansen-Møller J; Poulsen HD
J Anim Sci; 2018 Nov; 96(11):4693-4703. PubMed ID: 30085053
[TBL] [Abstract][Full Text] [Related]
10. Galactosyl hydroxylysine in assessment of Paget's bone disease.
Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
[TBL] [Abstract][Full Text] [Related]
11. Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism.
LoCascio V; Braga V; Bertoldo F; Bettica P; Pasini AF; Stefani L; Moro L
Clin Endocrinol (Oxf); 1994 Jul; 41(1):47-51. PubMed ID: 8050131
[TBL] [Abstract][Full Text] [Related]
12. Galactosyl hydroxylysine and deoxypyridinoline: a methodological comparison.
Bettica P; Baylink DJ; Moro L
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):459-65. PubMed ID: 8399787
[TBL] [Abstract][Full Text] [Related]
13. Urinary hydroxylysine and hydroxylysyl glycosides excretion in patients with Turner's syndrome.
Larizza D; Lorini R; Franchini M; Tenni R; Salvatoni A; Severi F
Horm Metab Res; 1985 Aug; 17(8):432-3. PubMed ID: 4054834
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion levels of hydroxylysine glycosides in osteoporotic patients.
Yoshihara K; Mochidome N; Hara T; Osada S; Takayama A; Nagata M
Biol Pharm Bull; 1994 Jun; 17(6):836-9. PubMed ID: 7951149
[TBL] [Abstract][Full Text] [Related]
15. Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease.
Blumsohn A; Naylor KE; Assiri AM; Eastell R
Clin Chem; 1995 Nov; 41(11):1592-8. PubMed ID: 7586548
[TBL] [Abstract][Full Text] [Related]
16. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
[TBL] [Abstract][Full Text] [Related]
17. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
Bettica P; Moro L; Robins SP; Taylor AK; Talbot J; Singer FR; Baylink DJ
Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
[TBL] [Abstract][Full Text] [Related]
18. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
[TBL] [Abstract][Full Text] [Related]
19. Urinary beta-1-galactosyl-0-hydroxylysine (GH) as a marker of collagen turnover of bone.
Moro L; Pozzi Mucelli RS; Gazzarrini C; Modricky C; Marotti F; de Bernard B
Calcif Tissue Int; 1988 Feb; 42(2):87-90. PubMed ID: 3127029
[TBL] [Abstract][Full Text] [Related]
20. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
